https://www.selleckchem.com/pr....oducts/carfilzomib-p
RESULTS The incidence of THA for patients aged 20 to 50 increased slightly from 33,003 in 2009 to 33,545 in 2016 (p less then 0.001). Overall, bearing surface type was reported in 46.8% (n=127,876) of THAs. Of the THAs with bearing surface codes, the use of MOP (29.6 to 18.7%) and MOM (39.6 to 4.4%) decreased, while COC (9.0 to 14.3%) and COP (21.8 to 62.6%) utilization increased (p less then 0.001 for all). Those receiving COC implants had the youngest average age (42 years) (p less then 0.001). Females were more likely to r
Like
Comment
Share
